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I MPAIRED MUCOSAL barrier function with resultant bacterial translocation (BT) are closely associated with 
infectious complications found in the intensive care unit 
and in transplanted patients. Lisofyllille [( R)-l-( 5-hydroxy-
hexyl)-3.7-dimethylxanthine 1 (LSF) selectively inhibits gen-
eration of phosphatidic acid. I which is a common second 
messenger to several pro-inflammatory mediators such as 
interleukin-I. tumor necrosis factor and LPS2 that are 
involved in the pathogenesis of BT and are mediators of the 
systemic inflammatory response syndrome.:' The goal of our 
study was to evaluate the protective effect of LSF in a 
well-established model of BT. 
MATERIALS AND METHODS 
Male ACI rats weighing 200 to 250 g (Harlan Sprague Dawley) 
were used for the study. The small howel (SB) was rendered 
ischemic by aseptically clamping the superior mesenteric artery for 
30 and 45 minutes while the animals were kept euthermic (37°C). 
The SB was repcrfused and the abdomen was sutured. Blood. 
mesenteric lymph nodes (MLN). spleen. liver. lung. and pancreas 
specimens were collected 24 hours after surgery for quantitative 
and qualitative microbiologic analvsis. Peritoneal swab cultures 
were performed at the time of laparotomy (control). at the end of 
surgery before abdominal closure (contamination control). and at 
sacrifice. LSF (25 mg/kg) was administered intravenously (IV) in 
the study groups before and after the insult while control animals 
received equal volume of sterile saline. Translocation of fluores-
cent latex microspheres. administered to thc rats 2.+ hours before 
experimentation in drinking water. was used to confirm the intes-
tinal origin of translocating particles and was assessed by fluores-
cent-activated cell sorter on peritoneal lavages. SB mucosal 
changes were also assessed by histopathological analysis. Sham 
untreated animals were used as controls (n = 6). The effect of LSF 
alone was tested on undamped animals (II = 4) while the effect of 
30 and 45 minutes of intestinal ischemia on BT was evaluated 
bctween untreated (II = 6: fl = 10. respectively) and LSF-treated 
rats (II = 6: n = 9. respectively). Fisher Exact Test was used to 
compare the proportions of positivc cultures and a P value of less 
than .05 was considered statistically signihcant. 
RESULTS 
The data summarized in Table 1 is expressed as a percent-
age of animals with positive organ cultures for Erischeria-
coli and/or enterococcus (> 1 X 104 bacteria) or peritoneal 
swabs with more than 300 colonies (P < .05). 
Intestinal ischemiaireperfusion injury was followed by 
significant translocation of bacteria to peritoneal cavity, 
MLN. liver, spleen, lung. and pancreas after 24 hours. Short 
treatment with IV LSF significantly decreased BT to liver. 
spleen. and lung. The sterility of the technique was ascer-
tained by sterile post-clamping peritoneal swabs in 100% of 
study animals. Translocation of bacteria in this model did 
not occur during the ischemic phase (ie. during clamping). 
BT did not occur in neither untreated nor LSF-trcated 
animals when exposed to only 30 minutes of intestinal 
ischemia. LSF treatment did not affect BT in unclamped 
controls. Histopathological evaluation of the SB did not 
show morphological significant differences between un-
treated and LSF-treated clamped groups. 
DISCUSSION AND CONCLUSIONS 
These data confirm that a significant BT occurs after a 
prolonged ischemic insult of the SB. A short course of IV 
LSF treatment significantly reduced BT to the liver, spleen. 
and lung when compared to untreated animals exposed to 
the same ischemic insult. The high morbidity and mortality 
associated with infective and septic complications in the 
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early post-transplant period emphasize the importance of a 
treatment directed to reduce BT in thIs condition. These 
ohservations suggest a potential helldicial role of LSF in 
reducing the rate of BT in critical can: of post-transplant 
patients. 
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